Table 3.
Fertility Preservation options for reproductive age women with breast cancer
| Fertility preservation option | Current status | Advantages | Disadvantages |
| Embryo Cryopreservation | Established | Highest cumulative pregnancy rates | Requires about two weeks delay in the initiation of cancer treatment |
| Requires hormonal stimulation for oocyte retrieval | |||
| Requires in vitro fertilization with male partner or donor sperm | |||
| Oocyte Cryopreservation | Established | No need for male partner or sperm donor | Requires about two weeks delay in the initiation of cancer treatment |
| Requires hormonal stimulation for oocyte retrieval | |||
| Ovarian Tissue Cryopreservation and Transplantation | Currently experimental, may change as success rates are rising | No need for hormonal stimulation | Requires outpatient laparoscopic surgery for ovarian tissue harvesting and subsequent transplantation |
| No need to significantly delay in the initiation of chemotherapy | |||
| No need for male partner or sperm donor |